Anzeige
Mehr »
Montag, 16.02.2026 - Börsentäglich über 12.000 News
FRIEDLANDS 10.000-JAHRE-SCHOCK: Der Kupfer-Engpass hat begonnen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
222 Leser
Artikel bewerten:
(1)

Guidewires Market 2018 - Global Forecast to 2022: Major Players are Boston Scientific, Abbott, Medtronic, Terumo and Cook Group

DUBLIN, Feb. 16, 2018 /PRNewswire/ --

The "Guidewires Market by Material (Nitinol, Stainless Steel, Hybrid), Product (Surgical, Diagnostic), Application (Cardiology, Vascular, Neurology, GIT, ENT, Urology, Oncology), End User (Hospital, ASCs) - Global Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global guidewires market is projected to reach USD 764.0 Million by 2022 from USD 605.2 Million in 2017, at a CAGR of 4.8%.

The growth witnessed by guidewires is mainly driven by the growing target patient population, continuous product launches by major manufacturers, increasing availability of medical reimbursements for guidewires across developed countries, and rising adoption of minimally invasive surgical procedures across major countries.

This report broadly segments the guidewire market into material, product, application, end user, and region. On the basis of material, the market is categorized into nitinol guidewires, stainless steel guidewires, and hybrid guidewires. In 2017, the nitinol guidewires segment is expected to account for the largest share of the market. This can be attributed to the growing number of target medical procedures that utilize nitinol guidewires, increasing applications of nitinol guidewires, and growing patient preference for minimally invasive surgeries.

On the basis of product, the market is categorized into surgical guidewires (further sub-segmented into hydrophilic and hydrophobic surgical guidewires) and diagnostic guidewires (further sub-segmented into hydrophilic and hydrophobic diagnostic guidewires). In 2017, the surgical guidewires segment is expected to account for the largest share of the market. It is also expected to register the highest CAGR during the forecast period. This can be attributed to the rising adoption of minimally invasive surgical procedures for the treatment of vascular diseases among medical professionals as well as patients, owing to its procedural benefits, and availability of reimbursements for vascular treatment procedures across developed countries.

Based on application, the market is categorized into cardiology, vascular, neurology, urology, gastroenterology, oncology, and otolaryngology. The cardiology applications segment accounted for the largest share of the market and it is expected to be the fastest-growing segment during the forecast period. The large share of this segment is attributed to the rising adoption of guidewires among cardiologists owing to procedural and technical benefits offered by nitinol materials used for manufacturing cardiology guidewires such as the biocompatibility, recovering elongation, resistivity, steerability, and super elasticity.

Based on end user, the market is segmented into three categories, namely, hospitals, diagnostic centers, and surgical centers; ambulatory care centers; and research laboratories & academic institutes. In 2017, the hospitals, diagnostic centers, and surgical centers segment is expected to account for the largest share of the market due to the rising group purchasing organizations (GPOs) across developed countries, the rising incidence of target diseases, and ongoing technological advancements in the field of minimally invasive surgeries.

The major players in the market are Boston Scientific (US), Abbott (US), Medtronic (Ireland), Terumo (Japan), and Cook Group (US).

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Guidewire Market, By Material

7 Guidewire Market, By Product

8 Guidewire Market, By Application

9 Guidewires Market, By End User

10 Guidewires Market, By Region

11 Competitive Landscape

12 Company Profiles

  • Abbott Laboratories
  • Angiodynamics
  • Asahi Intecc
  • B. Braun
  • Boston Scientific
  • C.R. Bard
  • Cardinal Health
  • Cook Group
  • Johnson & Johnson
  • Medtronic
  • Merit Medical Systems
  • Olympus Corporation
  • Stryker Corporation
  • Teleflex
  • Terumo Corporation

For more information about this report visit https://www.researchandmarkets.com/research/nwcvg8/guidewires_market?w=5

Media Contact:


Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716



© 2018 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.